Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,766 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients

NCT06551064

Conditions
Melanoma, Melanoma Stage III, Melanoma, Stage II, +11 more
Locations
  • Formycon Investigative Site Sarajevo, Bosnia and Herzegovina
  • Formycon Investigative Site Sofia, Bulgaria
  • Formycon Investigative Site Tartu, Estonia
  • Formycon Investigative Site Batumi, Georgia
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma

NCT04047251

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +15 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Dana Farber Cancer Institute (DFCI) Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, Not Recruiting

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

NCT05585320

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +29 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego San Diego, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

NCT05155254

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations
  • Mid Florida Hematology and Oncology Center Orange City, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • VCU Massey Cancer Center Richmond, Virginia, United States
View all 112 locations
View Trial Details
Active, Not Recruiting

A Prospective Natural History Study in Uveal Melanoma

NCT04588662

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT05864144

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +101 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Medical Aurora, Colorado, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Henry Ford Cancer Detroit, Michigan, United States
View Trial Details

Related conditions